Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 5, 2020, after the close
10-K filed Mar 5, 2020, 65 days after period end · 0000320017-20-000016
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $10.18M |
| Net Income | -$4.96M |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$3.56M |
| -$2.14M |
| -$5.44M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
